Advanced Biological Laboratories (ABL) / TherapyEdge INC

Activities

Staff number : 10-49

Description of activities

ABL is a SME, created in 2000 as a spin-off from the Public Research Centre for Health, holding large expertise in infectious diseases and more specifically in the molecular biology and clinical outcome predictors of HIV, hepatitis and HPV viruses.
As a clinical S/W and information company, ABL develops and provides decision support S/W for healthcare professionals who are caring for people with potentially life threatening chronic diseases.
ABL provides a comprehensive longitudinal database that measures the quality of care, identifies best practices, and assesses effectiveness through diagnostic testing. ABL´s vision is to help improve the quality of care for people living with HIV by assisting their healthcare providers with HIV specific therapeutic decision support and medical record systems that use the latest medical research and expertise in the field. HIV/AIDS, hepatitis and liver diseases, oncology and diabetis are the fields of expertise and interest.

Products and services

  • ABL´s patented web-based and local TherapyEdge Box System allows clinicians to identify and to deliver the best therapies for people living with complex, chronic diseases.
  • TherapyEdge-HIV is an HIV specific patient record, decision support, monitoring and reporting system with built in HIV specific decision support.
  • ViroScore Suite is an HIV drug resistance interpretation system and sequence storage database with built-in analysis and reporting tools.
  • TherapyEdge-Rapid Capture module was created in direct response to the needs of large hospitals and clinics that see a large number of HIV patients every day.
  • TherapyEdge Mobile Solutions enables data capture and medical decision support whilst healthcare professionals are visiting patients outside. Data synchronisation is made by Wifi and 3G communication.
  • TherapyEdge Down-Referral allows patients in a stable condition to receive their treatment in small clinics close to their homes.

Customer references

  • Centre de Recherche Publique - Santé, Luxembourg, Luxembourg
  • Rega Medical Institute, Catholic University Leuven, Belgium
  • Federal University of Sao Paulo, Sao Paulo, Brazil
  • GSK, BMS, Roche, Boehringer-Ingelheim, Abbott, and other pharmaceutical and diagnostic companies involved in HIV and hepatitis medicine

Trading area

International

Additional information

Development of a customised web-based data management system for the EU-sponsored research project SPREAD (Strategy to Control Spread of HIV Drug Resistance) and extended to the EU-sponsored Network of Excellence EuropeHIVResistance (Workpackage leader).

Research, Development and Innovation (RDI)

R&D investments (in % or by thousands of euros) : 60% of turnover in 2009

Industrial property

Licence(s) on the company's/research centre's technologies granted to third parties: Yes : Use of external technology under a licensing agreement or acquisition: Yes

Technological/technical capabilities

ABL is able to develop secure network (Intranet, Internet, VPN) platforms for the electronic management of clinical information between distributed units. ABL´s technology is a ready-to-run solution for all the technical problems that users face. The developed platforms are based on state-of-the-art technologies. ABL offers a service adapted to each clinical setting and can implement electronic case report forms. ABL can combine the secure collection of data with realtime analysis systems.

ABL is also able to develop specifically:

  • algorithm-based genotype interpretation systems;
  • tools for the management of sequences;
  • advanced genetic analysis tools to integrate complex clinical and virological information.

Equipment

TherapyEdge is a secure thin client-server platform for the electronic management of HIV-infected patients. It could be used by clinicians, virologists and also pharmaceutical companies, as well as CROs, for the secure collection of data and real-time management of HIV-related information.

It could be integrated to any type of network to:

  • implement new electronic case report forms;
  • engage specific data collection on investigating sites;
  • generate printout of case report forms in paper format (PDF);
  • display graphics for patients;
  • automate extraction and simple query on a frozen (purge) database;
  • generate message alerts.

Business sector(s)

  • Life Sciences, health and biotechnology
  • Technology Watch

Contact

Advanced Biological Laboratories (ABL) / TherapyEdge INC
2, rue des Dahlias; L-1411; Luxembourg; LUXEMBOURG
Luxembourg
Phone: +352 26 38 89 21
Fax: +352 26 38 89 38
Email: info@ablsa.com
Site: http://www.ablsa.com

R&D Contact

Mr SAYADA Chalom
Manager
Phone: +352 26 38 89 21
Email: chalom@ablsa.com

R&D Contact

Mr BOULME Ronan
Manager
Phone: +352 26 38 89 21
Email: ronan@ablsa.com

  • Updated 29-06-2015